Abstract:Maternal-fetal immune-tolerance occurs throughout the whole gestational trimester, thus a mother can accept a genetically distinct fetus without immunological aggressive behavior. HLA-G, one of the non-classical HLA class I molecules, is restricted-expression at extravillous trophoblast. It can concordantly interact with various kinds of receptors mounted on maternally immune cells residing in the uterus (e.g. CD4+ T cells, CD8+ T cells, natural killer cells, macrophages, and dendritic cells) for maintaining immune homeostasis of the maternal-fetus interface. HLA-G is widely regarded as the pivotal protective factor for successful pregnancies. In the past 20 years, researches associated with HLA-G have been continually published. Indeed, HLA-G plays a mysterious role in the mechanism of maternal-fetal immune-tolerance. It can also be ectopically expressed on tumor cells, infected sites and other pathologic microenvironments to confer a significant local tolerance. Understanding the characteristics of HLA-G in immunologic tolerance is not only beneficial for pathological pregnancy, but also helpful to the therapy of other immune-related diseases, such as organ transplant rejection, tumor migration, and autoimmune disease. In this review, we describe the biological properties of HLA-G, then summarize our understanding of the mechanisms of fetomaternal immunologic tolerance and the difference from transplant tolerance. Furthermore, we will discuss how HLA-G contributes to the tolerogenic microenvironment during pregnancy. Finally, we hope to find some new aspects of HLA-G in fundamental research or clinical application for the future.

The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells

The Role of Human Leukocyte Antigen G in Early Embryo Development and Implantation

HLA-G: An Important Mediator of Maternal-Fetal Immune-Tolerance

The Molecular Mechanisms of HLA-G Regulatory Function on Immune Cells during Early Pregnancy

Roles of HLA-G in the Maternal-Fetal Immune Microenvironment

HLA-G - evolvement from a trophoblast specific marker to a checkpoint molecule in cancer, a narrative review about the specific role in breast- and gynecological cancer

[HLA-G: from feto-maternal tolerance to organ acceptance]

Expression of HLA-G and its isoforms mRNA in human preimplantation embryos

Role of HLA-G1 in trophoblast cell proliferation, adhesion and invasion.

Differential Expression of Alternatively Spliced Transcripts of HLA-G in Human Preimplantation Embryos and Inner Cell Masses

Expression of HLA-G Protein in Human Preimplantation Embryos

Mechanism and function of human leucocyte antigen G at the interface of maternal-fetal tolerance

Human Leukocyte Antigens: the Unique Expression in Trophoblasts and Their Crosstalk with Local Immune Cells

HLA-G Genotype/Expression/Disease Association Studies: Success, Hurdles, and Perspectives

Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases

[The Involvement of Galectin-1 in Implantation and Pregnancy Maintenance at the Maternal-Fetal Interface].

HLA-G Expression/Secretion and T-Cell Cytotoxicity in Missed Abortion in Comparison to Normal Pregnancy

The Unique Expression Pattern of Human Leukocyte Antigen in Trophoblasts Potentially Explains the Key Mechanism of Maternal-Fetal Tolerance and Successful Pregnancy.

HLA-G: A New Immune Checkpoint in Cancer?

Role of Human Leukocyte Antigens at the Feto-Maternal Interface in Normal and Pathological Pregnancy: An Update

Three types of HLA-G+ extravillous trophoblasts that have distinct immune regulatory properties